Adagio Medical Holdings Cash Flow Statement (2023-2025) | ADGM

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -9.56M-5.91M-9.57M-7.42M-4.69M-7.89M-5.33M-6.39M-4.61M
Depreciation and Depletion (Quarter) 0.10M0.10M0.30M0.30M0.20M0.30M0.20M0.50M0.20M
Share-based Compensation (Quarter) 0.11M0.11M0.11M0.22M0.23M0.14M0.89M
Gains from Investment Securities (Quarter) 0.02M0.04M0.08M-0.09M0.01M-0.04M0.14M0.23M-0.35M
Asset Writedowns and Impairment (Quarter) 0.00M0.08M-0.04M-0.01M
Non-cash Items (Quarter) 0.07M0.00M0.07M2.00M5.70M2.60M
Cash from Operations (Quarter) -7.10M-6.74M-6.95M-6.36M-7.21M-4.14M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.01M0.01M0.01M
Depreciation & Amortization (CF) (Quarter) 0.10M0.13M0.33M0.26M0.32M0.27M0.20M0.50M0.24M
Change in Working Capital
Change in Receivables (Quarter) -0.00M-0.07M0.17M-0.01M-0.03M-0.00M
Change in Inventory (Quarter) 3.03M0.28M0.51M0.13M-0.26M0.12M
Change in Account Payables (Quarter) 0.88M0.87M-0.36M-0.19M0.06M
Change in Accured Expenses (Quarter) -0.22M0.68M-0.29M-0.65M-0.58M-1.50M
Other Working Capital Changes (Quarter) -0.29M-0.04M-0.04M1.26M-0.06M-0.61M
Investing Activities
Capital Expenditures (Quarter) 0.33M0.16M0.17M0.58M0.34M-0.49M
Cash from Investing Activities (Quarter) -0.02M-0.16M-0.17M-0.58M-0.34M0.49M
Financing Activities
Cash from Financing Activities (Quarter) 6.58M9.57M5.07M
Additional items
Exchange Rate Effect (Quarter) -0.07M0.03M0.01M0.04M-0.08M-0.06M
Change in Cash (Quarter) -0.60M2.70M-2.04M-6.89M-7.62M12.43M
Free Cash Flow (Quarter) -7.43M-6.90M-7.12M-6.94M-7.55M-3.65M
Net Cash Flow (Quarter) -0.54M2.67M-2.05M-6.94M-7.55M-3.65M